Walgreens Lidocaine Spray
- Manufacturer
- Walgreens Co | Derma Care Research Labs, LLC
- Effective date
- 2023-11-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:18:25
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Lidocaine HCl 5%, Phenylephrine HCl 0.25%, Witch Hazel 50%
OTC - PURPOSE SECTION
Anorectal; anesthetic, vasoconstrictor, astringent
INDICATIONS & USAGE SECTION
- Temporarily shrinks hemorrhoidal tissue
- Temporarily reduces the swelling and irritation associated with hemorrhoids and other anorectal disorders
- aids in protecting irritated anorectal areas
INDICATIONS & USAGE SECTION
Temporarily shrinks hemorrhoidal tissue. Temporarily reduces the swelling and irritation associated with hemorrhoids and other anorectal disorders. Aids in protecting irritated anorectal areas.
WARNINGS SECTION
For external use only.
Flammable. Do not use while smoking or near heat or flame.
When using this product
- keep away from children
- avoid spraying in eyes
- contents under pressure. Do not puncture or incinerate. Do not store at temperatures above 120F
- do not exceed the recommended daily dosage unless directed by a doctor
- do not put this product into the rectum by using fingers or any mechanical device or applicator
- certain persons can develop allergic reactions to ingredients in this product. If the symptoms being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase, discontinue use and consult a doctor.
Ask a doctor or pharmacist before use if you have
- heart disease, high blood pressure, thyroid disease, diabetes, difficulty in urination due to enlargement of the prostate gland
- are presently taking a prescription drug for high blood pressure or depression
Stop use and ask a doctor if
- bleeding occurs
- condition worsens
- symptoms persist for more than 7 days or clear up and occur again within a few days
- needed for longer than 1 week
OTC - PREGNANCY OR BREAST FEEDING SECTION
Ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
If swallowed, get medical help or contact a Poison Control Center immediately (1-800-222-1222).
DOSAGE & ADMINISTRATION SECTION
- Adults: when practical, cleanse the affected are with an appropriate cleansing wipe.
- Spray rectal area until thoroughly moist. Wipe off excess with tissue.
- Gently dry by patting or blotting with a tissue or a soft cloth.
- Apply to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement.
- Children under 12 years of age, consult a doctor.
INACTIVE INGREDIENT SECTION
alcohol, aloe barbadensis leaf extract, anthemis nobilis flower extract, benzophenone-4, benzyl alcohol, centella asiatica extract,disodium EDTA, epilobium angustifolium extract, ethylhexylglycerin, glycerin, hydroxyethylcellulose, polysorbte 40, propylene glycol, sodium citrate, tocopherol, tocopheryl acetate, water.
OTC - QUESTIONS SECTION
1-800-925-4733
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- Lidocaine Hemorrhoid
- Lidocaine 5%, Phenylephrine HCl 0.25%, Witch Hazel 50%
- CENTELLA ASIATICA TRITERPENOIDS
- POLYSORBATE 40
- SODIUM CITRATE
- WATER
- SULISOBENZONE
- BENZYL ALCOHOL
- ALCOHOL
- WITCH HAZEL
- PHENYLEPHRINE HYDROCHLORIDE
- PHENYLEPHRINE
- LIDOCAINE
- EPILOBIUM ANGUSTIFOLIUM LEAF
- .ALPHA.-TOCOPHEROL ACETATE
- CHAMAEMELUM NOBILE FLOWER
- GLYCERIN
- HYDROXYETHYL CELLULOSE, UNSPECIFIED
- ETHYLHEXYLGLYCERIN
- EDETATE DISODIUM
- PROPYLENE GLYCOL
- TOCOPHEROL
- ALOE VERA LEAF
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0363-1567 | 0363-1567-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 10a7742a-613d-92ae-e063-6394a90a7409 | 05b76342-598d-fab8-e063-6394a90aa939 | 2024-02-05 | Warnings | 05b76342-598d-fab8-e063-6394a90aa939 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
